Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A newer class of diabetes drugs may offer an extra benefit: A new study suggests these medications lower the odds of suffering heart failure.
Researchers from Henry Ford Hospital in Detroit found that patients taking so-called GLP-1 drugs ? including brand-name medications such as Byetta, Januvia and Victoza ? were more than 40 percent less likely to be hospitalized for heart failure than patients prescribed other blood sugar-lowering medications. GLP-1 diabetes drugs have been in use for only the last several years and are considered second-line treatments after well-established medications such as metformin, physicians said.
http://news.health.com/2013/03/10/certain-diabetes-medications-may-lower-heart-failure-risk/
Researchers from Henry Ford Hospital in Detroit found that patients taking so-called GLP-1 drugs ? including brand-name medications such as Byetta, Januvia and Victoza ? were more than 40 percent less likely to be hospitalized for heart failure than patients prescribed other blood sugar-lowering medications. GLP-1 diabetes drugs have been in use for only the last several years and are considered second-line treatments after well-established medications such as metformin, physicians said.
http://news.health.com/2013/03/10/certain-diabetes-medications-may-lower-heart-failure-risk/